Cree Inc. (NASDAQ:CREE): Needham believes that, in the third quarter, the demand for LED devices will peak, and will result in a slowdown in the second half of 2012. The firm expects to have less of a demand to increase prices along the entire supply chain, so they have lowered their estimates for Cree (NASDAQ:CREE), Aixtron (NASDAQ:AIXG), and Veeco (NASDAQ:VECO). Needham anticipates a limited near-term upside for LED stocks, but keeps a Buy rating on Cree and Hold ratings on Aixtron and Veeco.
Don’t Miss: Is Nasdaq BULLYING Facebook Stock Traders?
Onyx Pharmaceuticals Inc. (NASDAQ:ONXX): After the drug, Kyprolis, for patients with Multiple Myeloma, was approved earlier than expected, Bernstein increased their target on Onyx Pharmaceuticals Inc. The firm, believes that they could generate close to $6 per share in 2015. They cited higher than expected pricing and strong labeling as the main reasons for their target increase. BMO maintains an Outperform rating on the stock.
Manpower Inc. (NYSE:MAN): Based on the European slowdown and increased macro headwinds, Credit Suisse lowered their Manpower estimates. The firm expects shares to remain volatile in the near term, but believes that they offer a strong long term, risk reward. Shares are Outperform rated.
Schlumberger Limited (NYSE:SLB): Citing a less than expected decline in NAM margins, but improvement in international pricing trends, Susquehanna increased their estimate on Schlumberger. Shares are Positive rated and their price target was raised from $80 to $81.
Asia Entertainment & Resources (NASDAQ:AERL): After meeting with Asia Entertainment’s management, Stifel Nicolaus sharply reduced their estimates, citing a slower Macau VIP market and tighter lending conditions for the company’s agents. However, the firm views their stock’s valuation as inexpensive, so they maintain a Buy rating on their shares.
Don’t Miss: Is Google Jazzing Up Its Email CROWN JEWEL?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.